00:00It's Benzinga, bringing Wall Street to Main Street.
00:02A U.S. judge on Monday rejected Novo Nordisk's request to block Eli Lilly from running advertisements
00:09for weight loss drugs that Novo Nordisk claims are false and misleading, according to Reuters.
00:14U.S. District Judge Zahid Quraishi ruled that Novo Nordisk failed to demonstrate irreparable
00:19harm from the advertisements. Novo Nordisk sued Eli Lilly in July, alleging that ads comparing
00:26higher doses of Zepbound and Monjaro with lower doses of Wegovy and Ozempic violated false
00:32advertising laws. The judge found that the ads had a negligible market impact between April
00:37and July, while prescriptions for Novo Nordisk's products remained stable. Novo Nordisk said
00:44the litigation remains ongoing and Eli Lilly denied wrongdoing.
